glp 1 bcbs Medicare Bridge Program Explained: GLP-1 Medications for Weight Loss Blue Cross Blue Shield of

doi: 10.1007/s11357-011-9303-8 183 YoshinoYIshisakaMTsujiiSShimazawaMHaraH

The move greatly broadens access for existing players like Lilly and Novo, but could cool incentives for new competitors and push back obesity drug innovation

GLP-1 is a hormone made up of 30 or 31 amino acids

Existing extended-release options, like weekly formulations of semaglutide and dulaglutide, have reduced injection frequency, and future innovations may include monthly formulations or implantable devices that deliver continuous therapy

For patients who are gaining weight during treatment, or who are struggling with weight after treatment, these medications may offer another option to support overall health and wellbeing

CMS used its demonstration authority to create a workaround